Souhaitez-vous accéder aux communiqués récents ?

FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq:...

WARRINGTON, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage...

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...

Duos Continues to Lead in Railcar Inspection Innovation with Its obliquevue® System used for advanced undercarriage visualization for AI analytics JACKSONVILLE, Fla., Jan. 14, 2025 (GLOBE...

Egnyte introduced 300 features to enhance data management, including its AI-powered Egnyte Copilot and was granted five new patents in 2024.

Cincinnati, OH, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ensemble, ranked consistently as the number one revenue cycle managed services company for healthcare organizations, announced today the United...

Shoals Technologies Group, Inc., maintains commitment to protecting U.S. Solar Manufacturing, files additional patent infringement complaint with ITC.

Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The cancer peptide drugs market has experienced significant growth in recent years, with over 30 peptide-based therapies currently approved for clinical use...

Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights: mRNA Cancer Vaccines In Clinical Trials: > 60...

CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...